港股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

同源康醫藥-B

12.600

-0.070-0.55%

成交量：116.32萬

成交額：1,469.51萬

市值：47.89億

市盈率：-9.66

高：12.770

開：12.480

低：12.480

收：12.670

52周最高：46.100

52周最低：12.100

股本：3.80億

香港流通股本：3.75億

量比：1.82

換手率：0.31%

股息：- -

股息率：- -

每股收益(LYR):-1.304

淨資產收益率：--

總資產收益率：-27.71%

市淨率：11.79

市盈率(LYR):-9.66

市銷率: 39329.07

資料載入中...

總覽公司新聞資訊公告

同源康醫藥-B(02410)：同源康生物將獲增資8350萬元

同源康醫藥與多方達成協議向泰科生物增資649萬元

每日沽空追蹤 | 同源康醫藥-B 02月25日沽空量成交2.45萬股，沽空比例為2.34%

每日沽空追蹤 | 同源康醫藥-B 02月16日沽空量成交1500股，沽空比例為1.74%

每日沽空追蹤 | 同源康醫藥-B 02月13日沽空量成交1.3萬股，沽空比例為1.15%

同源康醫藥-B02月13日主力淨流入76.5萬元散户資金拋售

同源康醫藥-B(02410)：聯交所就實施H股全流通授出上市批准

每日沽空追蹤 | 同源康醫藥-B 02月11日沽空量成交7000股，沽空比例為0.42%

同源康醫藥-B02月10日遭主力拋售93.1萬元

同源康醫藥-B(02410)：甲磺酸艾多替尼片（TY-9591片）的新藥上市申請獲國家藥品監督管理局受理

同源康醫藥－Ｂ(02410)股價上升5%，現價港幣$13.23

阿斯达克财经

港股異動 | 同源康醫藥-B(02410)午後漲近5% 甲磺酸艾多替尼片獲納入優先審評品種名單

每日沽空追蹤 | 同源康醫藥-B 02月04日沽空量成交500股，沽空比例為0.06%

浙江同源康醫藥（2410）1月無新增發行或股份變動

每日沽空追蹤 | 同源康醫藥-B 02月02日沽空量成交9000股，沽空比例為0.36%

同源康醫藥-B02月02日遭主力拋售50.3萬元

港股異動 | 同源康醫藥-B(02410)早盤升逾13% 甲磺酸艾多替尼片獲納入優先審評品種名單

同源康醫藥-B旗下阿散德替尼獲國家藥監局藥品審評中心納入優先審評品種名單

同源康醫藥-B(02410)在研1類新藥甲磺酸艾多替尼片被國家藥品監督管理局藥品審評中心納入優先審評品種名單

每日沽空追蹤 | 同源康醫藥-B 01月29日沽空量成交7.9萬股，沽空比例為3.21%

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/02410/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02410","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02410\",,,,,undefined,":{"symbol":"02410","market":"HK","secType":"STK","nameCN":"同源康醫藥-B","latestPrice":12.6,"timestamp":1772179699175,"preClose":12.67,"halted":0,"volume":1163241,"delay":0,"changeRate":-0.005524861878453061,"floatShares":375457818,"shares":380065818,"eps":-1.3042750659155808,"marketStatus":"未開盤","change":-0.07,"latestTime":"02-27 16:08:19","open":12.48,"high":12.77,"low":12.48,"amount":14695072,"amplitude":0.022889,"askPrice":12.72,"askSize":10500,"bidPrice":12.6,"bidSize":5500,"shortable":3,"etf":0,"ttmEps":-0.8783705187184602,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1772415000000},"marketStatusCode":0,"adr":0,"listingDate":1724083200000,"exchange":"SEHK","adjPreClose":12.67,"openAndCloseTimeList":[[1772155800000,1772164800000],[1772168400000,1772179200000]],"volumeRatio":1.8202722862186307,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02410\",,,,,undefined,":{"symbol":"02410","floatShares":375457818,"roa":"-27.71%","roe":"--","lyrEps":-1.304275,"volumeRatio":1.8202722862186307,"shares":380065818,"dividePrice":0,"high":12.77,"amplitude":0.022889,"preClose":12.67,"low":12.48,"week52Low":12.1,"pbRate":"11.79","psRate":"39329.07","week52High":46.1,"institutionHeld":0,"latestPrice":12.6,"committee":-0.3125,"eps":-1.3042750659155808,"divideRate":0,"volume":1163241,"delay":0,"ttmEps":-0.8783705187184602,"open":12.48,"prevYearClose":13.11,"prevWeekClose":12.6,"prevMonthClose":12.6,"prevQuarterClose":13.11,"fiveDayClose":12.98,"twentyDayClose":12.49,"sixtyDayClose":13.2},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02410\",params:#limit:5,,,undefined,":[{"date":"2025-08-31","symbol":"02410","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756603800000,"name":null,"time":"","dateTimestamp":1756569600000,"actualEps":null},{"date":"2025-03-27","symbol":"02410","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1743039000000,"name":null,"time":"","dateTimestamp":1743004800000,"actualEps":null},{"date":"2024-08-30","symbol":"02410","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1724981400000,"name":null,"time":"","dateTimestamp":1724947200000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02410\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02410\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":1,"updateTime":1747324800000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02410\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02410","date":"2026-02-27","current":-14.356086,"percent":0.930667,"low":-45.171338,"twenty":-24.827654,"median":-18.801141,"eighty":-15.988536,"high":-10.104382,"avg":-20.702824,"sd":6.127577,"marketCap":4788829306},"quantilePoints":[{"date":"2024-08-23","current":-18.036629,"twenty":-16.647141,"median":-14.72623,"eighty":-12.008468,"marketCap":8010053668},{"date":"2024-08-30","current":-17.916348,"twenty":-18.108709,"median":-17.490261,"eighty":-14.277882,"marketCap":8010053668},{"date":"2024-09-06","current":-22.38992,"twenty":-20.387629,"median":-17.957821,"eighty":-15.985061,"marketCap":10531737231},{"date":"2024-09-13","current":-25.215246,"twenty":-24.52304,"median":-18.767123,"eighty":-16.911292,"marketCap":11829662594},{"date":"2024-09-20","current":-22.432724,"twenty":-24.518581,"median":-20.496807,"eighty":-17.208183,"marketCap":10587362603},{"date":"2024-09-27","current":-24.719835,"twenty":-24.497927,"median":-22.38992,"eighty":-17.671485,"marketCap":11736953639},{"date":"2024-10-04","current":-24.95032,"twenty":-24.87878,"median":-23.321155,"eighty":-17.932937,"marketCap":11792579012},{"date":"2024-10-10","current":-25.38933,"twenty":-24.941363,"median":-23.362473,"eighty":-17.973583,"marketCap":11922371548},{"date":"2024-10-18","current":-26.355956,"twenty":-25.311733,"median":-23.798709,"eighty":-18.108709,"marketCap":12311749157},{"date":"2024-10-25","current":-24.571342,"twenty":-25.374683,"median":-24.122054,"eighty":-18.545067,"marketCap":11477368567},{"date":"2024-11-01","current":-18.445843,"twenty":-25.311733,"median":-23.998666,"eighty":-18.584118,"marketCap":8621932768},{"date":"2024-11-08","current":-20.323115,"twenty":-25.278482,"median":-23.623818,"eighty":-17.973583,"marketCap":9456313359},{"date":"2024-11-15","current":-19.45318,"twenty":-25.171449,"median":-23.425489,"eighty":-18.108709,"marketCap":8955685004},{"date":"2024-11-22","current":-24.620137,"twenty":-24.988066,"median":-23.362473,"eighty":-18.406793,"marketCap":11329034239},{"date":"2024-11-29","current":-31.047836,"twenty":-25.311733,"median":-23.554037,"eighty":-18.584118,"marketCap":14277178993},{"date":"2024-12-06","current":-34.758675,"twenty":-25.786797,"median":-23.737743,"eighty":-19.168188,"marketCap":15945940174},{"date":"2024-12-13","current":-35.961329,"twenty":-26.0415,"median":-24.070769,"eighty":-19.324298,"marketCap":16465110319},{"date":"2024-12-20","current":-44.500897,"twenty":-30.298107,"median":-24.44033,"eighty":-19.494791,"marketCap":20284719244},{"date":"2024-12-27","current":-43.273475,"twenty":-31.455257,"median":-24.553474,"eighty":-19.619623,"marketCap":19709923726},{"date":"2025-01-03","current":-39.042242,"twenty":-33.760908,"median":-24.669986,"eighty":-19.709581,"marketCap":17800119264},{"date":"2025-01-10","current":-16.73771,"twenty":-34.083555,"median":-24.719835,"eighty":-19.709581,"marketCap":7602134269},{"date":"2025-01-17","current":-16.071561,"twenty":-33.760908,"median":-24.553474,"eighty":-18.860667,"marketCap":7305465614},{"date":"2025-01-24","current":-20.268382,"twenty":-32.413923,"median":-24.349989,"eighty":-19.230133,"marketCap":9270895450},{"date":"2025-01-28","current":-18.549699,"twenty":-31.591026,"median":-24.122054,"eighty":-18.549699,"marketCap":8529223814},{"date":"2025-02-07","current":-17.965815,"twenty":-31.472067,"median":-23.871541,"eighty":-18.275892,"marketCap":8214013368},{"date":"2025-02-14","current":-19.878813,"twenty":-31.451054,"median":-23.623818,"eighty":-18.275892,"marketCap":9066935750},{"date":"2025-02-21","current":-25.066745,"twenty":-31.047836,"median":-23.789321,"eighty":-18.32609,"marketCap":11495910358},{"date":"2025-02-28","current":-26.244856,"twenty":-30.411824,"median":-23.765234,"eighty":-18.39703,"marketCap":11996538712},{"date":"2025-03-07","current":-24.725844,"twenty":-30.135297,"median":-23.927628,"eighty":-18.445843,"marketCap":11347576030},{"date":"2025-03-14","current":-23.101371,"twenty":-29.84324,"median":-23.977848,"eighty":-18.549699,"marketCap":10605904394},{"date":"2025-03-21","current":-22.868028,"twenty":-28.789228,"median":-23.789321,"eighty":-18.691799,"marketCap":10494653649},{"date":"2025-03-28","current":-28.703724,"twenty":-28.703724,"median":-23.977848,"eighty":-19.110968,"marketCap":13146129748},{"date":"2025-04-03","current":-29.204856,"twenty":-29.744706,"median":-24.122054,"eighty":-19.131966,"marketCap":12070705875},{"date":"2025-04-11","current":-24.387234,"twenty":-29.307899,"median":-24.067881,"eighty":-19.145106,"marketCap":10012567086},{"date":"2025-04-17","current":-24.599189,"twenty":-28.955479,"median":-24.067881,"eighty":-19.224594,"marketCap":10123817831},{"date":"2025-04-25","current":-24.758022,"twenty":-28.755026,"median":-24.236021,"eighty":-19.282593,"marketCap":10197984995},{"date":"2025-05-02","current":-30.859428,"twenty":-28.772127,"median":-24.368612,"eighty":-19.308976,"marketCap":12738210348},{"date":"2025-05-09","current":-26.222368,"twenty":-28.789228,"median":-24.487968,"eighty":-19.376573,"marketCap":11477368567},{"date":"2025-05-16","current":-19.875071,"twenty":-28.703724,"median":-24.44033,"eighty":-19.45318,"marketCap":8770267095},{"date":"2025-05-23","current":-18.391406,"twenty":-28.460584,"median":-24.320388,"eighty":-19.147078,"marketCap":8139846205},{"date":"2025-05-30","current":-16.767615,"twenty":-28.328721,"median":-24.116277,"eighty":-18.777931,"marketCap":7453799941},{"date":"2025-06-06","current":-19.720458,"twenty":-27.077703,"median":-23.93026,"eighty":-18.847277,"marketCap":8788808886},{"date":"2025-06-13","current":-16.18601,"twenty":-26.697665,"median":-23.850097,"eighty":-18.709822,"marketCap":7216465018},{"date":"2025-06-20","current":-14.05098,"twenty":-26.664525,"median":-23.778892,"eighty":-18.426653,"marketCap":6252291891},{"date":"2025-06-27","current":-16.3221,"twenty":-26.630078,"median":-23.66211,"eighty":-18.32609,"marketCap":7283215465},{"date":"2025-07-04","current":-17.493079,"twenty":-26.41078,"median":-23.623818,"eighty":-18.194509,"marketCap":7806093968},{"date":"2025-07-11","current":-16.487526,"twenty":-26.267076,"median":-23.430941,"eighty":-17.964216,"marketCap":7349965912},{"date":"2025-07-18","current":-15.867745,"twenty":-26.226866,"median":-23.321155,"eighty":-17.866761,"marketCap":7068130691},{"date":"2025-07-25","current":-16.407488,"twenty":-26.143659,"median":-23.070409,"eighty":-17.335488,"marketCap":7335132480},{"date":"2025-08-01","current":-14.539711,"twenty":-26.072617,"median":-22.868028,"eighty":-17.325642,"marketCap":6459959949},{"date":"2025-08-08","current":-15.316665,"twenty":-25.987382,"median":-22.563641,"eighty":-17.04089,"marketCap":6822181433},{"date":"2025-08-15","current":-17.450454,"twenty":-25.968574,"median":-22.406203,"eighty":-16.915178,"marketCap":7760944003},{"date":"2025-08-22","current":-13.484776,"twenty":-25.95357,"median":-22.354126,"eighty":-16.718364,"marketCap":5978435317},{"date":"2025-08-29","current":-12.516323,"twenty":-25.925655,"median":-21.46252,"eighty":-16.486483,"marketCap":5575565550},{"date":"2025-09-05","current":-19.23268,"twenty":-25.919389,"median":-21.226743,"eighty":-16.486483,"marketCap":5883418862},{"date":"2025-09-12","current":-18.156363,"twenty":-25.850806,"median":-20.678772,"eighty":-16.541494,"marketCap":5564163575},{"date":"2025-09-19","current":-18.839434,"twenty":-25.807696,"median":-20.500943,"eighty":-16.56352,"marketCap":5769399117},{"date":"2025-09-26","current":-19.348832,"twenty":-25.743581,"median":-20.268382,"eighty":-16.654406,"marketCap":5910023469},{"date":"2025-10-03","current":-22.468168,"twenty":-25.650075,"median":-20.314843,"eighty":-16.707921,"marketCap":6879191305},{"date":"2025-10-10","current":-19.927643,"twenty":-25.596841,"median":-20.323115,"eighty":-16.732368,"marketCap":6092455062},{"date":"2025-10-17","current":-19.134493,"twenty":-25.519561,"median":-20.155539,"eighty":-16.749672,"marketCap":5845412280},{"date":"2025-10-24","current":-17.635142,"twenty":-25.404318,"median":-19.980008,"eighty":-16.781291,"marketCap":5389333299},{"date":"2025-10-31","current":-19.024541,"twenty":-25.400784,"median":-19.927643,"eighty":-16.830147,"marketCap":5822608331},{"date":"2025-11-07","current":-17.694439,"twenty":-25.37593,"median":-19.869193,"eighty":-16.945559,"marketCap":5412137248},{"date":"2025-11-14","current":-17.099248,"twenty":-25.321084,"median":-19.741813,"eighty":-16.951188,"marketCap":5244908288},{"date":"2025-11-21","current":-15.19815,"twenty":-25.311733,"median":-19.694587,"eighty":-16.919035,"marketCap":4659606928},{"date":"2025-11-28","current":-16.711808,"twenty":-25.293455,"median":-19.641679,"eighty":-16.730587,"marketCap":5142290517},{"date":"2025-12-05","current":-17.262657,"twenty":-25.275139,"median":-19.635782,"eighty":-16.587841,"marketCap":5320921452},{"date":"2025-12-12","current":-16.160016,"twenty":-25.213434,"median":-19.544821,"eighty":-16.497144,"marketCap":4990264190},{"date":"2025-12-19","current":-16.355316,"twenty":-25.19336,"median":-19.414876,"eighty":-16.454475,"marketCap":5062476695},{"date":"2025-12-24","current":-15.692499,"twenty":-25.154877,"median":-19.348832,"eighty":-16.406101,"marketCap":4872443786},{"date":"2026-01-02","current":-15.765099,"twenty":-25.10227,"median":-19.292077,"eighty":-16.35327,"marketCap":4914251026},{"date":"2026-01-09","current":-17.392186,"twenty":-25.070347,"median":-19.235279,"eighty":-16.345574,"marketCap":5434941197},{"date":"2026-01-16","current":-16.438751,"twenty":-25.06473,"median":-19.137216,"eighty":-16.35327,"marketCap":5153692492},{"date":"2026-01-23","current":-15.75073,"twenty":-25.023112,"median":-19.120814,"eighty":-16.314941,"marketCap":4933254317},{"date":"2026-01-30","current":-15.280433,"twenty":-24.971672,"median":-19.022068,"eighty":-16.22453,"marketCap":4807832597},{"date":"2026-02-06","current":-15.542994,"twenty":-24.952303,"median":-18.937078,"eighty":-16.152588,"marketCap":4902849052},{"date":"2026-02-13","current":-15.334427,"twenty":-24.923448,"median":-18.860882,"eighty":-16.099082,"marketCap":4864842470},{"date":"2026-02-20","current":-15.572498,"twenty":-24.905533,"median":-18.847277,"eighty":-16.071561,"marketCap":4933254317},{"date":"2026-02-27","current":-14.952615,"twenty":-24.827654,"median":-18.801141,"eighty":-15.988536,"marketCap":4788829306}],"updateTime":1772410048158},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02410\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2614585894","title":"同源康醫藥-B(02410)：同源康生物將獲增資8350萬元","url":"https://stock-news.laohu8.com/highlight/detail?id=2614585894","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614585894?lang=zh_tw&edition=fundamental","pubTime":"2026-02-27 20:06","pubTimestamp":1772194014,"startTime":"0","endTime":"0","summary":"增资完成后，同源康生物的总注册资本将由人民币1400万元增加至约人民币2049万元，而公司于同源康生物的权益将由约57.14%减少至39.03%，且同源康生物将不再为集团的附属公司。因此，该等交易将使集团能够将其资源集中于集团营运的其他方面，使集团能够更好地管理其营运，同时保留于同源康生物的重大权益及参与程度。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1408388.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","02410","09939","BK1574","BK1515","159938"],"gpt_icon":0},{"id":"1141594891","title":"同源康醫藥與多方達成協議 向泰科生物增資649萬元","url":"https://stock-news.laohu8.com/highlight/detail?id=1141594891","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1141594891?lang=zh_tw&edition=fundamental","pubTime":"2026-02-27 19:57","pubTimestamp":1772193435,"startTime":"0","endTime":"0","summary":"同源康医药股份有限公司近日宣布，已与相关投资方共同签署协议，决定对旗下泰科生物（Tyk Bio）进行增资扩股。根据协议条款，本次增资总额为人民币649万元，将全部用于增加泰科生物的注册资本。\n此次增资完成后，泰科生物的资本实力将得到进一步增强，有助于加速其在生物医药领域的研发进程和业务拓展。市场分析认为，这一举措体现了股东对泰科生物发展前景的信心，也将为同源康医药在创新药领域的布局提供更有力的支撑。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02410"],"gpt_icon":0},{"id":"2614906193","title":"每日沽空追蹤 | 同源康醫藥-B 02月25日沽空量成交2.45萬股，沽空比例為2.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2614906193","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614906193?lang=zh_tw&edition=fundamental","pubTime":"2026-02-25 16:30","pubTimestamp":1772008234,"startTime":"0","endTime":"0","summary":"同源康医药-B北京时间02月25日，跌1.34%，卖空量成交2.45万股，较上一交易日增加512.5%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260225163421a4c6754d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260225163421a4c6754d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1515","02410","BK1161","09939"],"gpt_icon":0},{"id":"2612243314","title":"每日沽空追蹤 | 同源康醫藥-B 02月16日沽空量成交1500股，沽空比例為1.74%","url":"https://stock-news.laohu8.com/highlight/detail?id=2612243314","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612243314?lang=zh_tw&edition=fundamental","pubTime":"2026-02-16 16:30","pubTimestamp":1771230627,"startTime":"0","endTime":"0","summary":"同源康医药-B北京时间02月16日，跌0.31%，卖空量成交1500股，较上一交易日减少94.12%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260216163339a4a9f7a0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260216163339a4a9f7a0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1515","09939","BK1574","02410","BK1161"],"gpt_icon":0},{"id":"2611815925","title":"每日沽空追蹤 | 同源康醫藥-B 02月13日沽空量成交1.3萬股，沽空比例為1.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2611815925","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611815925?lang=zh_tw&edition=fundamental","pubTime":"2026-02-13 16:30","pubTimestamp":1770971432,"startTime":"0","endTime":"0","summary":"同源康医药-B北京时间02月13日，涨1.03%，卖空量成交1.3万股，较上一交易日增加333.33%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260213163438a49ff9e5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260213163438a49ff9e5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1515","02410","09939","BK1574"],"gpt_icon":0},{"id":"2611137547","title":"同源康醫藥-B02月13日主力淨流入76.5萬元 散户資金拋售","url":"https://stock-news.laohu8.com/highlight/detail?id=2611137547","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611137547?lang=zh_tw&edition=fundamental","pubTime":"2026-02-13 16:15","pubTimestamp":1770970526,"startTime":"0","endTime":"0","summary":"02月13日, 同源康医药-B股价涨1.03%，报收12.80元，成交金额1435.5万元，换手率0.30%，振幅2.37%，量比0.48。同源康医药-B今日主力资金净流入76.5万元，上一交易日主力净流出86.9万元。该股近5个交易日下跌0.47%，主力资金累计净流出288.0万元，其中1个交易日为股价上涨时净流出；近20日主力资金累计净流出827.2万元，其中净流出天数为12日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260213161647a49fe5ad&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260213161647a49fe5ad&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1515","02410","BK1161","09939"],"gpt_icon":0},{"id":"2610945167","title":"同源康醫藥-B(02410)：聯交所就實施H股全流通授出上市批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2610945167","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610945167?lang=zh_tw&edition=fundamental","pubTime":"2026-02-12 17:07","pubTimestamp":1770887224,"startTime":"0","endTime":"0","summary":"智通财经APP讯，同源康医药-B(02410)公布，公司已向联交所上市委员会申请批准公司根据转换公司1名股东持有的460.8万股非上市股份转换的460.8万股H股上市及买卖经转换H股。联交所已于2026年2月11日授出上市批准。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1404690.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02410","BK1515","BK1574","BK1161","159938","09939"],"gpt_icon":0},{"id":"2610961373","title":"每日沽空追蹤 | 同源康醫藥-B 02月11日沽空量成交7000股，沽空比例為0.42%","url":"https://stock-news.laohu8.com/highlight/detail?id=2610961373","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610961373?lang=zh_tw&edition=fundamental","pubTime":"2026-02-11 16:30","pubTimestamp":1770798633,"startTime":"0","endTime":"0","summary":"同源康医药-B北京时间02月11日，跌1.41%，卖空量成交7000股，较上一交易日减少81.08%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260211163427a6ee1e74&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260211163427a6ee1e74&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1515","BK1161","09939","02410","BK1574"],"gpt_icon":0},{"id":"2610605754","title":"同源康醫藥-B02月10日遭主力拋售93.1萬元","url":"https://stock-news.laohu8.com/highlight/detail?id=2610605754","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610605754?lang=zh_tw&edition=fundamental","pubTime":"2026-02-10 16:16","pubTimestamp":1770711368,"startTime":"0","endTime":"0","summary":"02月10日, 同源康医药-B股价跌0.78%，报收12.76元，成交金额2489.9万元，换手率0.51%，振幅3.89%，量比0.87。同源康医药-B今日主力资金净流出93.1万元，上一交易日主力净流出134.1万元。该股近5个交易日上涨3.24%，主力资金累计净流出3.5万元；近20日主力资金累计净流出211.7万元，其中净流出天数为12日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260210162335a492ad01&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260210162335a492ad01&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1574","02410","BK1515","09939"],"gpt_icon":0},{"id":"2609856571","title":"同源康醫藥-B(02410)：甲磺酸艾多替尼片（TY-9591片）的新藥上市申請獲國家藥品監督管理局受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2609856571","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609856571?lang=zh_tw&edition=fundamental","pubTime":"2026-02-06 17:02","pubTimestamp":1770368535,"startTime":"0","endTime":"0","summary":"智通财经APP讯，同源康医药-B 发布公告，本公司在研1类新药甲磺酸艾多替尼片的新药上市申请被国家药品监督管理局药品审评中心受理。甲磺酸艾多替尼片作为奥希替尼的氘代化合物，无论是从化学结构、药理作用、临床有效性和安全性、以及耐药机制分析，甲磺酸艾多替尼片都显示出更明显的临床价值和优势，对疾病的预后有明显改善作用。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1402563.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","BK1515","TY","02410","159938","09939","BK1574"],"gpt_icon":0},{"id":"2609355446","title":"同源康醫藥－Ｂ(02410)股價上升5%，現價港幣$13.23","url":"https://stock-news.laohu8.com/highlight/detail?id=2609355446","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609355446?lang=zh_tw&edition=fundamental","pubTime":"2026-02-06 14:34","pubTimestamp":1770359640,"startTime":"0","endTime":"0","summary":"[上升股]同源康医药－Ｂ(02410) 股价在下午02:34比前收市价上升5%，现股价为港币$13.23。至目前为止，今日最高价为$13.23，而最低价为$12.33。总成交量为277.35万股，总成交金额为港币$3.561千万。","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180112133338093_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180112133338093_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2602062089/aamm-all-category","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2602062089/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1515","09939","BK1574","02410","BK1161","159938"],"gpt_icon":0},{"id":"2609786559","title":"港股異動 | 同源康醫藥-B(02410)午後漲近5% 甲磺酸艾多替尼片獲納入優先審評品種名單","url":"https://stock-news.laohu8.com/highlight/detail?id=2609786559","media":"智通财经","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609786559?lang=zh_tw&edition=fundamental","pubTime":"2026-02-06 14:19","pubTimestamp":1770358758,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，同源康医药-B(02410)午后涨近5%，截至发稿，涨3.65%，报13.06港元，成交额2890.62万港元。消息面上，同源康医药此前公布，公司在研1类新药甲磺酸艾多替尼片(TY-9591片)被国家药品监督管理局(NMPA)药品审评中心(CDE)纳入优先审评品种名单。据悉，该药物拟用于治疗具有表皮生长因子受体(EGFR)外显子19缺失或外显子21置换突变，并伴有中枢神经系统转移的局部晚期或转移性非小细胞肺癌(NSCLC)成人患者的一线治疗。此次被纳入优先评审，标志着甲磺酸艾多替尼片的审评进程将全面提速，有望更早上市，为中国患者提供新的治疗选择。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1402459.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02410","VT","BK1574","BK4585","VXUS","BK4588","159938","BK1161","BK1515","09939"],"gpt_icon":0},{"id":"2608986043","title":"每日沽空追蹤 | 同源康醫藥-B 02月04日沽空量成交500股，沽空比例為0.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2608986043","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608986043?lang=zh_tw&edition=fundamental","pubTime":"2026-02-04 16:30","pubTimestamp":1770193830,"startTime":"0","endTime":"0","summary":"同源康医药-B北京时间02月04日，涨0.08%，卖空量成交500股，较上一交易日减少80%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260204163637a6d20465&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260204163637a6d20465&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","09939","BK1515","02410","BK1161"],"gpt_icon":0},{"id":"1110153215","title":"浙江同源康醫藥（2410）1月無新增發行或股份變動","url":"https://stock-news.laohu8.com/highlight/detail?id=1110153215","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1110153215?lang=zh_tw&edition=fundamental","pubTime":"2026-02-03 17:36","pubTimestamp":1770111387,"startTime":"0","endTime":"0","summary":"浙江同源康医药股份有限公司（02410）于2026年2月3日披露截至2026年1月31日的股份变动月报表。公告显示，公司当月未有新增发行、购回或注销等股份变动事宜，股本结构维持稳定。\n公司注册股本总计为人民币380,065,818元，其中H股股份数为375,457,818股，非上市股份数为4,608,000股。本月报表显示，上述H股与非上市股份数量均无增减，分别保持在375,457,818股和4,608,000股。\n根据公告，公司确认当前符合香港联交所主板上市规则所要求的公众持股量规定，且并无股份期权、股权激励计划或可转换债券等相关变动。月报由执行董事、董事长兼总裁吴豫生签署。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02410"],"gpt_icon":0},{"id":"2608850786","title":"每日沽空追蹤 | 同源康醫藥-B 02月02日沽空量成交9000股，沽空比例為0.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2608850786","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608850786?lang=zh_tw&edition=fundamental","pubTime":"2026-02-02 16:30","pubTimestamp":1770021030,"startTime":"0","endTime":"0","summary":"同源康医药-B北京时间02月02日，跌3%，卖空量成交9000股，较上一交易日减少50%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260202163651a6c985c4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260202163651a6c985c4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02410","BK1574","BK1161","BK1515","09939"],"gpt_icon":0},{"id":"2608713850","title":"同源康醫藥-B02月02日遭主力拋售50.3萬元","url":"https://stock-news.laohu8.com/highlight/detail?id=2608713850","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608713850?lang=zh_tw&edition=fundamental","pubTime":"2026-02-02 16:15","pubTimestamp":1770020129,"startTime":"0","endTime":"0","summary":"02月02日, 同源康医药-B股价跌3.00%，报收12.27元，成交金额3124.7万元，换手率0.67%，振幅6.09%，量比0.58。同源康医药-B今日主力资金净流出50.3万元，连续5日净流出，上一交易日主力净流出65.1万元。该股近5个交易日下跌3.39%，主力资金累计净流出742.7万元，其中1个交易日为股价上涨时净流出；近20日主力资金累计净流入427.8万元，其中净流入天数为6日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260202161753a6c97173&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260202161753a6c97173&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02410","09939","BK1515","BK1574"],"gpt_icon":0},{"id":"2607306694","title":"港股異動 | 同源康醫藥-B(02410)早盤升逾13% 甲磺酸艾多替尼片獲納入優先審評品種名單","url":"https://stock-news.laohu8.com/highlight/detail?id=2607306694","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607306694?lang=zh_tw&edition=fundamental","pubTime":"2026-01-30 09:35","pubTimestamp":1769736942,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，同源康医药-B(02410)早盘涨超13%，截至发稿，涨8.94%，报13.52港元，成交额4070.33万港元。消息面上，同源康医药公布，公司在研1类新药甲磺酸艾多替尼片(TY-9591片)被国家药品监督管理局(NMPA)药品审评中心(CDE)纳入优先审评品种名单。据悉，该药物拟用于治疗具有表皮生长因子受体(EGFR)外显子19缺失或外显子21置换突变，并伴有中枢神经系统转移的局部晚期或转移性非小细胞肺癌(NSCLC)成人患者的一线治疗。此次被纳入优先评审，标志着甲磺酸艾多替尼片的审评进程将全面提速，有望更早上市，为中国患者提供新的治疗选择。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1399541.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1574","BK4585","02410","BK1515","VT","159938","BK1161","09939","BK4588"],"gpt_icon":0},{"id":"1193030035","title":"同源康醫藥-B旗下阿散德替尼獲國家藥監局藥品審評中心納入優先審評品種名單","url":"https://stock-news.laohu8.com/highlight/detail?id=1193030035","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1193030035?lang=zh_tw&edition=fundamental","pubTime":"2026-01-29 17:16","pubTimestamp":1769678166,"startTime":"0","endTime":"0","summary":"同源康医药股份有限公司宣布，其研发的阿散德替尼（Asandeutertinib）已被中国国家药品监督管理局药品审评中心正式纳入优先审评品种名单。这一重要进展标志着该药物在临床价值和市场潜力方面获得了监管机构的高度认可。\n优先审评资格的获得，将有望显著缩短阿散德替尼的审评审批时间，加速其在中国市场的上市进程，从而惠及更多患者。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02410"],"gpt_icon":0},{"id":"2607702571","title":"同源康醫藥-B(02410)在研1類新藥甲磺酸艾多替尼片被國家藥品監督管理局藥品審評中心納入優先審評品種名單","url":"https://stock-news.laohu8.com/highlight/detail?id=2607702571","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607702571?lang=zh_tw&edition=fundamental","pubTime":"2026-01-29 17:08","pubTimestamp":1769677696,"startTime":"0","endTime":"0","summary":"智通财经APP讯，同源康医药-B(02410)公布，公司在研1类新药甲磺酸艾多替尼片(TY-9591片)被国家药品监督管理局(NMPA)药品审评中心(CDE)纳入优先审评品种名单。甲磺酸艾多替尼片(TY-9591片)拟定的适应症为具有EGFR外显子19缺失(19DEL) 或外显子21(L858R)置换突变，并伴有CNS转移的局部晚期或转移性NSCLC成人患者的一线治疗。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1399178.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["09939","BK1515","BK1574","02410","BK1161","159938"],"gpt_icon":0},{"id":"2607037664","title":"每日沽空追蹤 | 同源康醫藥-B 01月29日沽空量成交7.9萬股，沽空比例為3.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2607037664","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607037664?lang=zh_tw&edition=fundamental","pubTime":"2026-01-29 16:30","pubTimestamp":1769675432,"startTime":"0","endTime":"0","summary":"同源康医药-B北京时间01月29日，跌0.32%，卖空量成交7.9万股，较上一交易日增加558.33%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260129164013a6bae324&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260129164013a6bae324&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09939","BK1515","BK1161","BK1574","02410"],"gpt_icon":0}],"pageSize":20,"totalPage":7,"pageCount":1,"totalSize":126,"code":"91000000","status":"200"}]}}